These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37513441)

  • 1. Synthesis of Benzocycloalkanone-Based Michael Acceptors and Biological Activities as Antimalarial and Antitrypanosomal Agents.
    Mijoba A; Fernandez-Moreira E; Parra-Giménez N; Espinosa-Tapia S; Blanco Z; Ramírez H; Charris JE
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
    Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
    Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents.
    Mendoza-Martínez C; Correa-Basurto J; Nieto-Meneses R; Márquez-Navarro A; Aguilar-Suárez R; Montero-Cortes MD; Nogueda-Torres B; Suárez-Contreras E; Galindo-Sevilla N; Rojas-Rojas Á; Rodriguez-Lezama A; Hernández-Luis F
    Eur J Med Chem; 2015; 96():296-307. PubMed ID: 25899334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phthalazine derivatives containing imidazole rings behave as Fe-SOD inhibitors and show remarkable anti-T. cruzi activity in immunodeficient-mouse mode of infection.
    Sánchez-Moreno M; Gómez-Contreras F; Navarro P; Marín C; Olmo F; Yunta MJ; Sanz AM; Rosales MJ; Cano C; Campayo L
    J Med Chem; 2012 Nov; 55(22):9900-13. PubMed ID: 23043291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity of 1,2,3-triazole-2-amino-1,4-naphthoquinone derivatives and their evaluation as therapeutic strategy for malaria control.
    Costa Souza RM; Montenegro Pimentel LML; Ferreira LKM; Pereira VRA; Santos ACDS; Dantas WM; Silva CJO; De Medeiros Brito RM; Andrade JL; De Andrade-Neto VF; Fujiwara RT; Bueno LL; Silva Junior VA; Pena L; Camara CA; Rathi B; De Oliveira RN
    Eur J Med Chem; 2023 Jul; 255():115400. PubMed ID: 37130472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.
    Gulin JEN; Eagleson MA; López-Muñoz RA; Solana ME; Altcheh J; García-Bournissen F
    Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
    Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
    Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi.
    Reis RCFM; Dos Santos EG; Benedetti MD; Reis ACC; Brandão GC; Silva GND; Diniz LA; Ferreira RS; Caldas IS; Braga SFP; Souza TB
    Eur J Med Chem; 2023 Oct; 258():115622. PubMed ID: 37441850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro tripanocidal effect of 1,8-dioxooctahydroxanthenes (xanthenodiones) and tetraketones and improvement of cardiac parameters in vivo.
    Menezes APJ; Silva MLD; Pereira WL; Costa GP; Horta AL; Mendonça AAS; Carneiro ACA; Souza DMS; Novaes RD; Teixeira RR; Talvani A
    J Glob Antimicrob Resist; 2020 Sep; 22():466-476. PubMed ID: 32417591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hit-to-lead optimization of novel 2-alkylaminomethylquinoline derivatives as anti-chagas agents.
    Muscia GC; Roldán Pacheco FJ; Asís SE; Buldain GY; Frank FM
    Eur J Med Chem; 2020 Jan; 186():111877. PubMed ID: 31771829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational modification of Mannich base-type derivatives as novel antichagasic compounds: Synthesis, in vitro and in vivo evaluation.
    Paucar R; Martín-Escolano R; Moreno-Viguri E; Azqueta A; Cirauqui N; Marín C; Sánchez-Moreno M; Pérez-Silanes S
    Bioorg Med Chem; 2019 Sep; 27(17):3902-3917. PubMed ID: 31345745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coumarins isolated from Calophyllum brasiliense produce ultrastructural alterations and affect in vitro infectivity of Trypanosoma cruzi.
    Rodríguez-Hernández KD; Martínez I; Agredano-Moreno LT; Jiménez-García LF; Reyes-Chilpa R; Espinoza B
    Phytomedicine; 2019 Aug; 61():152827. PubMed ID: 31039535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4, 5-Dihydrooxazole-pyrazoline hybrids: Synthesis and their evaluation as potential antimalarial agents.
    Pandey AK; Sharma S; Pandey M; Alam MM; Shaquiquzzaman M; Akhter M
    Eur J Med Chem; 2016 Nov; 123():476-486. PubMed ID: 27494165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
    Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
    Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, β-hematin inhibition studies and antimalarial evaluation of new dehydroxy isoquine derivatives against Plasmodium berghei: A promising antimalarial agent.
    Valverde EA; Romero AH; Acosta ME; Gamboa N; Henriques G; Rodrigues JR; Ciangherotti C; López SE
    Eur J Med Chem; 2018 Mar; 148():498-506. PubMed ID: 29126722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives.
    Jonckers TH; van Miert S; Cimanga K; Bailly C; Colson P; De Pauw-Gillet MC; van den Heuvel H; Claeys M; Lemière F; Esmans EL; Rozenski J; Quirijnen L; Maes L; Dommisse R; Lemière GL; Vlietinck A; Pieters L
    J Med Chem; 2002 Aug; 45(16):3497-508. PubMed ID: 12139461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antimalarial activity of E-2-quinolinylbenzocycloalcanones.
    Charris JE; Domínguez JN; Gamboa N; Rodrigues JR; Angel JE
    Eur J Med Chem; 2005 Sep; 40(9):875-81. PubMed ID: 15878218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquinone synthesis pathway is a promising drug target for Chagas disease.
    Nara T; Nakagawa Y; Tsuganezawa K; Yuki H; Sekimata K; Koyama H; Ogawa N; Honma T; Shirouzu M; Fukami T; Matsuo Y; Inaoka DK; Kita K; Tanaka A
    PLoS One; 2021; 16(2):e0243855. PubMed ID: 33539347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives.
    Moreno-Viguri E; Jiménez-Montes C; Martín-Escolano R; Santivañez-Veliz M; Martin-Montes A; Azqueta A; Jimenez-Lopez M; Zamora Ledesma S; Cirauqui N; López de Ceráin A; Marín C; Sánchez-Moreno M; Pérez-Silanes S
    J Med Chem; 2016 Dec; 59(24):10929-10945. PubMed ID: 28002965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.